A Randomized, Open-label, 3-way Crossover Phase I Study in Type 2 Diabetes Mellitus Patients Treated With Metformin to Evaluate the Pharmacokinetics and Pharmacodynamics of Simvastatin During Coadministration With AZD1656 and to Evaluate the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs AZD 1656; Simvastatin
- Indications Lipid metabolism disorders; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 05 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 05 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Apr 2010 New trial record